Pathogenesis of Higher Blood Pressure and Worse Renal Function in Salt-Sensitive Hypertension
Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in norma...
Saved in:
Published in | Kidney & blood pressure research Vol. 46; no. 2; pp. 236 - 244 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.04.2021
Karger Publishers |
Subjects | |
Online Access | Get full text |
ISSN | 1420-4096 1423-0143 1423-0143 |
DOI | 10.1159/000515088 |
Cover
Loading…
Abstract | Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series. Results: The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group. Conclusions: Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed. |
---|---|
AbstractList | The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain.
We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series.
The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group.
Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed. The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain.BACKGROUNDThe underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain.We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series.METHODSWe recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series.The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group.RESULTSThe SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group.Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed.CONCLUSIONSDifferences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed. Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. Methods: We recruited 329 subjects, 131 in salt-sensitive (SS) group, 148 in nonsalt-sensitive (NSS) group, and 50 healthy people in normal group and tested their renal function, 24-h ambulatory blood pressure, and growth factor series. Results: The SS group showed worse renal function with lower estimated glomerular filtration rate and higher urinary microalbumin, α-microglobulin, urinary protein Cr ratio, and urinary immunoglobulin. Most indicators in 24-h ambulatory blood pressure of the SS group were significantly enhanced than the NSS group, indicating their higher blood pressure. The significantly elevated growth factors in the SS group were AR, BMP-5, EG-VEGF, GH, HGF, IGFBP-2, IGFBP-3, IGFBP-6, MCSFR, NT-4, PDGF-AA, SCF, SCFR, VEGFR2, VEGFR3, and VEGF-D, compared to other 2 groups or one of them. PI3K-AKT pathway was activated in the SS group. Conclusions: Differences in growth factors and pathways may account for the manifestations of the SS group. Activated PI3K-AKT pathway with higher IGFBP-3 and GH can lead to renal damage. Higher MCSFR in the SS group indicates that high blood pressure and severe kidney damage may be associated with the activation of the immune system. EG-VEGF, VEGFR2, VEGFR3, and VEGF-D can also explain the elevated blood pressure due to the dilated lymphatic system which drains excess sodium and water back into circulation. The SS group presented higher AR and HGF which may worsen renal function by regulating cell proliferation and tumor formation. However, due to the potential low awareness rate of hypertension at the very beginning, we cannot ensure the exact occurrence order of blood pressure, renal damage, and salt sensitivity. Therefore, further studies which can track data from the onset of hypertension are needed. |
Author | Chu, Yuguang Zhou, Yan Lu, Shihua Hu, Yuanhui Lu, Feng |
Author_xml | – sequence: 1 givenname: Yuguang surname: Chu fullname: Chu, Yuguang – sequence: 2 givenname: Yan surname: Zhou fullname: Zhou, Yan – sequence: 3 givenname: Shihua surname: Lu fullname: Lu, Shihua – sequence: 4 givenname: Feng surname: Lu fullname: Lu, Feng – sequence: 5 givenname: Yuanhui surname: Hu fullname: Hu, Yuanhui email: *Yuanhui Hu, huiyuhui55@sohu.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33794518$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0ctvEzEQB2ALFdEHHLgjZIkLHJba68euj7SipKISVQvihFYT72zqsLGD7UXqf4_ThByqXvzS559GM8fkwAePhLzm7CPnypwyxhRXrG2fkSMua1ExLsXBw5lVkhl9SI5TWm4YY_ULcihEY6Ti7RH5dQ35LizQY3KJhoHO3OIOIz0bQ-jpdcSUpogUfE9_hpiQ3qCHkV5M3mYXPHWe3sKYq1v0yWX3F-nsfo0xb67BvyTPBxgTvtrtJ-THxefv57Pq6tuXy_NPV5VVguXKGGu11E0_Rw4GBTKUwBVqBC373oKyzEKLZZFD3WgJjSqoFrogo0CckMttbh9g2a2jW0G87wK47uEhxEUHMTs7YmeNkEbXXDCjpGoEWN3O22bOaw1o675kvd9mrWP4M2HK3coli-MIHsOUuro0WhnOuC703SO6DFMs_dkoKaRoSo-LertT03yF_b68_0Mo4MMW2BhSijjsCWfdZsDdfsDFnj6y1mXYjCJHcOOTP3ZF_oa4wLjP_np2sxXduh-KevOk2oX8A4tpuZg |
CitedBy_id | crossref_primary_10_1159_000542828 crossref_primary_10_3390_nu15071732 crossref_primary_10_1016_j_ultsonch_2022_106150 crossref_primary_10_3899_jrheum_220635 crossref_primary_10_1080_17425255_2024_2398628 crossref_primary_10_3389_fcvm_2023_1205475 |
Cites_doi | 10.1038/s41581-019-0121-z 10.1556/650.2019.31308 10.1159/000180580 10.1158/1078-0432.CCR-07-4499 10.1016/0002-9343(78)90045-1 10.1002/0471140864.ps2701s72 10.2337/diabetes.51.7.2270 10.1161/01.cir.55.5.779 10.1016/j.ihj.2017.09.223 10.1016/S0140-6736(97)05189-1 10.1093/eurheartj/eht151 10.1097/HJH.0b013e3283375974 10.1158/1078-0432.CCR-08-0071 10.1093/nar/gkw1092 10.1007/s11906-018-0903-x 10.1161/01.hyp.17.1_suppl.i61 |
ContentType | Journal Article |
Copyright | 2021 The Author(s). Published by S. Karger AG, Basel 2021 The Author(s). Published by S. Karger AG, Basel. |
Copyright_xml | – notice: 2021 The Author(s). Published by S. Karger AG, Basel – notice: 2021 The Author(s). Published by S. Karger AG, Basel. |
DBID | M-- AAYXX CITATION NPM 3V. 7QL 7T7 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. M0S M1P M7N P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS S0X 7X8 DOA |
DOI | 10.1159/000515088 |
DatabaseName | Karger Open Access CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China SIRS Editorial MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Technology Research Database ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Technology Research Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: M-- name: Karger Open Access url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1423-0143 |
EndPage | 244 |
ExternalDocumentID | oai_doaj_org_article_c934962130954573ac68b87b126aec2d 33794518 10_1159_000515088 515088 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0R~ 0~B 29L 30W 327 36B 3O. 3V. 4.4 5GY 5RE 5VS 7X7 88E 8AO 8FI 8FJ 8UI AAYIC ABOCM ABPAZ ABUWG ACGFO ACGFS ACPRK ADBBV ADFRT AENEX AEYAO AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CS3 CYUIP DIK DU5 E0A EBS EMB EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HZ~ IAO IHR IHW KQ8 KUZGX M-- M1P N9A O1H O9- OK1 P2P PQQKQ PROAC PSQYO RIG RKO RNS S0X SV3 UJ6 UKHRP .GJ 34G 39C 53G AAYXX ABBTS ABWCG ACQXL ADAGL AFJJK AFSIO AHFRZ APPQY CAG CITATION COF EJD IPNFZ ITC PHGZM PHGZT RXVBD ZXP NPM PJZUB PPXIY 7QL 7T7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c530t-99cc6467dbe1a9e3e0e4a15e6ea64ddca5c0ca8e0ca4f2764a753e023615e95a3 |
IEDL.DBID | DOA |
ISSN | 1420-4096 1423-0143 |
IngestDate | Wed Aug 27 01:18:02 EDT 2025 Fri Jul 11 06:44:28 EDT 2025 Fri Jul 25 21:21:27 EDT 2025 Mon Jul 21 05:38:57 EDT 2025 Thu Apr 24 22:57:54 EDT 2025 Tue Jul 01 05:07:30 EDT 2025 Thu Aug 29 12:04:35 EDT 2024 Thu Sep 05 18:04:37 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Ambulatory blood pressure Salt-sensitive hypertension Renal damage PI3K-AKT signaling pathway Growth factor |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. https://creativecommons.org/licenses/by-nc/4.0 2021 The Author(s). Published by S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c530t-99cc6467dbe1a9e3e0e4a15e6ea64ddca5c0ca8e0ca4f2764a753e023615e95a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/c934962130954573ac68b87b126aec2d |
PMID | 33794518 |
PQID | 2543437518 |
PQPubID | 33949 |
PageCount | 9 |
ParticipantIDs | proquest_journals_2543437518 karger_primary_515088 proquest_miscellaneous_2508591016 pubmed_primary_33794518 doaj_primary_oai_doaj_org_article_c934962130954573ac68b87b126aec2d crossref_primary_10_1159_000515088 crossref_citationtrail_10_1159_000515088 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-04-01 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Kidney & blood pressure research |
PublicationTitleAlternate | Kidney Blood Press Res |
PublicationYear | 2021 |
Publisher | S. Karger AG Karger Publishers |
Publisher_xml | – name: S. Karger AG – name: Karger Publishers |
References | Kinsara AJ. Ambulatory blood pressure monitoring in daily practice. Indian Heart J. 2017 Nov–Dec;69(6):788–9. Fehrenbach DJ, Mattson DL. Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension. Am J Physiol Ren Physiol. 2020;318:544–8. Toschi L, Jänne PA. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res. 2008;14(19):5941–6. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, . Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350(9093):1734–7. Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20(12):103. Mattson DL. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage. Nat Rev Nephrol. 2019;15(5):290–300. Sulyok E. [New aspects of the pathomechanism of salt-sensitive hypertension]. Orv Hetil. 2019;160(2):43–9. Luft FC, Grim CE, Willis LR, Higgins JT, Weinberger MH. Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation. 1977;55(5):779–84. Sutandy FX, Qian J, Chen CS, Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci. 2013;Chapter 27:Unit 27.1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. National Health and Family Planning Commission. Report on nutrition and chronic diseases of Chinese residents(2015).Version 1. Beijing: People's Health Publishing House; 2015. p. 48. Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens. 2010;28(5):1020–6. Thirone AC, Scarlett JA, Gasparetti AL, Araujo EP, Lima MH, Carvalho CR, . Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes. 2002;51(7):2270–81. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension. 1991;17(1 Suppl):I61–8. Yamada M, Ichikawa Y, Yamagishi S, Momiyama N, Ota M, Fujii S, . Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin Cancer Res. 2008;14(8):2351–6. Varma SS, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020 May 5;8:286. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. AM J MED. 1978;64(2):193–8. Ren J, Crowley SD. Role of T-cell activation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2019;316:1345–53. ref13 ref12 ref15 ref14 ref11 ref10 ref2 ref1 ref17 ref16 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – reference: Lu X, Crowley SD. Inflammation in salt-sensitive hypertension and renal damage. Curr Hypertens Rep. 2018;20(12):103. – reference: Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension. 1991;17(1 Suppl):I61–8. – reference: Toschi L, Jänne PA. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res. 2008;14(19):5941–6. – reference: Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. – reference: Fehrenbach DJ, Mattson DL. Inflammatory macrophages in the kidney contribute to salt-sensitive hypertension. Am J Physiol Ren Physiol. 2020;318:544–8. – reference: Ren J, Crowley SD. Role of T-cell activation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2019;316:1345–53. – reference: Yamada M, Ichikawa Y, Yamagishi S, Momiyama N, Ota M, Fujii S, . Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer. Clin Cancer Res. 2008;14(8):2351–6. – reference: Thirone AC, Scarlett JA, Gasparetti AL, Araujo EP, Lima MH, Carvalho CR, . Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Diabetes. 2002;51(7):2270–81. – reference: Kinsara AJ. Ambulatory blood pressure monitoring in daily practice. Indian Heart J. 2017 Nov–Dec;69(6):788–9. – reference: Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. – reference: Mattson DL. Immune mechanisms of salt-sensitive hypertension and renal end-organ damage. Nat Rev Nephrol. 2019;15(5):290–300. – reference: Sulyok E. [New aspects of the pathomechanism of salt-sensitive hypertension]. Orv Hetil. 2019;160(2):43–9. – reference: National Health and Family Planning Commission. Report on nutrition and chronic diseases of Chinese residents(2015).Version 1. Beijing: People's Health Publishing House; 2015. p. 48. – reference: Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–61. – reference: Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. AM J MED. 1978;64(2):193–8. – reference: Sutandy FX, Qian J, Chen CS, Zhu H. Overview of protein microarrays. Curr Protoc Protein Sci. 2013;Chapter 27:Unit 27.1. – reference: Varma SS, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020 May 5;8:286. – reference: Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, . Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350(9093):1734–7. – reference: Luft FC, Grim CE, Willis LR, Higgins JT, Weinberger MH. Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation. 1977;55(5):779–84. – reference: Chamarthi B, Williams JS, Williams GH. A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II. J Hypertens. 2010;28(5):1020–6. – ident: ref6 doi: 10.1038/s41581-019-0121-z – ident: ref12 doi: 10.1556/650.2019.31308 – ident: ref11 doi: 10.1159/000180580 – ident: ref15 doi: 10.1158/1078-0432.CCR-07-4499 – ident: ref3 doi: 10.1016/0002-9343(78)90045-1 – ident: ref8 doi: 10.1002/0471140864.ps2701s72 – ident: ref14 doi: 10.1038/s41581-019-0121-z – ident: ref17 doi: 10.2337/diabetes.51.7.2270 – ident: ref2 doi: 10.1161/01.cir.55.5.779 – ident: ref7 doi: 10.1016/j.ihj.2017.09.223 – ident: ref5 doi: 10.1016/S0140-6736(97)05189-1 – ident: ref10 doi: 10.1093/eurheartj/eht151 – ident: ref4 doi: 10.1097/HJH.0b013e3283375974 – ident: ref16 doi: 10.1158/1078-0432.CCR-08-0071 – ident: ref9 doi: 10.1093/nar/gkw1092 – ident: ref13 doi: 10.1007/s11906-018-0903-x – ident: ref1 doi: 10.1161/01.hyp.17.1_suppl.i61 |
SSID | ssj0005002 |
Score | 2.2835858 |
Snippet | Background: The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains... The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains uncertain. We... The underlying pathogenesis of patients with salt-sensitive hypertension expressing higher blood pressure and severer renal damage remains... |
SourceID | doaj proquest pubmed crossref karger |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 236 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein ambulatory blood pressure Blood pressure Cell proliferation Damage Glomerular filtration rate growth factor Growth factors Health care Hospitals Hypertension Immune system Insulin-like growth factor-binding protein 2 Insulin-like growth factor-binding protein 3 Insulin-like growth factor-binding protein 6 Lymphatic system Medical research Mortality Neurotrophin 4 Pathogenesis Patients pi3k-akt signaling pathway Platelet-derived growth factor Population Proteins renal damage Renal function Research Article Salt salt-sensitive hypertension Salts Software Statistical analysis Traditional Chinese medicine Vascular endothelial growth factor Vascular endothelial growth factor receptors Water circulation |
SummonAdditionalLinks | – databaseName: Karger Open Access dbid: M-- link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwEB1BkapeELQFAgUZhBCXSNnEduJjF7FagRahlopeUOTYk6qiJFV2e-DfM2Nnw4foJQd7EkeesWfGfn4GeO0r6b1Ek6qssamsPA2pSrtUNV61qKXOkdchV5_08kx-OFfn43oHn4X5zvjnQI06cQuQww1XzzFzeXUX7lEeVTBL_ipNf4M5sogulJQMUcaiRw6hv17dg92iIPNTfMHHH04ocPWTA4pN3x5pBo-zeAD3x1BRHEfdPoQ72O3DwXFHafKPn-KNCODNsCq-D7urcY_8AL59pqCuv-A57HIt-lZEKIeYM0RdxOOAAwrbefG1H9YoTpCbWZCDYyWJy06c2qtNesrQdp4MxZJy1SEg3fvuEM4W77-8W6bjJQqpU0W2SY1xjrq89A3OrMECM5R2plCj1aQmZ5XLnK2QHrLNSy0tJTDIvPIkZJQtHsFO13f4BIQtTauKcuaog6X0lW18ZnNsTakaiguzBN5ue7V2I8M4X3RxVYdMQ5l60kUCrybR60ir8T-hOatmEmAm7FDQDxf1OLBqZ5jyPidXbCgYLAvrdNVUZTPLtUWX-wQOo2Knz2w_fvRP-cf5Sayqr31L1VszqMdRva7zcA6XN6oSeDlV03jkTRbbYX_DMkwZx2siCTyO5jO1sDW_p7f80zPYyxkyE4BBR7CzGW7wOcU8m-ZFMPdf8in2zQ priority: 102 providerName: Karger AG – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLgrbQQKkMQohLRDbxIz6hbtXVClSEWir2giLHnlQVJVmy2wP_nhnHmwpUuOwhnnUkjz0vf_mGsde-FN4LMKnMapuK0uORKpVLZe1lA0qoHKgOefJJzc_Fh4VcxILbKsIqNzYxGGrfOaqRv8vDN5B0SfB--TOlrlF0uxpbaNxl94i6jCBdeqFvIB7ZgDkUmCJhHqMisxB68NDLjqjQyz_8UaDtR1_0nVDY_b-DzuB8Zo_Ywxg18sNBzY_ZHWi32c5hixnzj1_8DQ84zlAg32b3T-J1-Q779hnju-6CzNnlincNH1AdfEpodT58GdgDt63nX7t-BfwU6DUz9HWkL37Z8jN7tU7PCOVOdpHPMW3tA-i9a3fZ-ez4y9E8jf0UUieLbJ0a4xyuvvY1TKyBAjIQdiJBgVWoMWely5wtAX9Ek2slLOYyQBTzKGSkLZ6wrbZrYY9xq00jCz1xuKpC-NLWPrM5NEbLGkPELGFvN6tauUg2Tj0vrqqQdEhTjQpI2KtRdDkwbNwmNCXVjAJEih0edP1FFc9Y5Qyx3-folQ3GhbqwTpV1qetJriy43Cdsd1DsOM1m8v2_nn-cng5D1dI3OLzZBlU84KvqZjsm7OU4jEeT7ltsC901yRB7HJVHEvZ02D7jG4oCDSH--9n_J3_OHuQEoglQoX22te6v4QVGQev6IGz134LsAlA priority: 102 providerName: ProQuest |
Title | Pathogenesis of Higher Blood Pressure and Worse Renal Function in Salt-Sensitive Hypertension |
URI | https://karger.com/doi/10.1159/000515088 https://www.ncbi.nlm.nih.gov/pubmed/33794518 https://www.proquest.com/docview/2543437518 https://www.proquest.com/docview/2508591016 https://doaj.org/article/c934962130954573ac68b87b126aec2d |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgLog8gUFYGIcQlIpvYTnzsoq5WoK2qLRV7QZFjT1DVNqmy2wP_nhk7iaACceGSQzx5ecbzsL98ZuytK4RzAnQsk8rEonA4pAplY1k5WYMSKgWah1yeqMW5-LSW61-2-iJMWKAHDh33wWqiNE_R1WoM9nlmrCqqIq-mqTJgU0feF2PeUEwN4I4koA0FFkdYwaieUwhjt9_FjkjQi98ikSfsxyh0Sfjr7u_ppg878yfscZ8v8qPwnrvsHjR7bP-owVr5-gd_xz2C00-N77GHy36hfJ99O8XMrv1Ojuxiw9uaBzwHnxFOnYd_AjvgpnH8a9ttgK-AHjPHKEea4hcNPzNX2_iM8O3kEfkCC9bOw93b5oCdz4-_fFzE_U4KsZVZso21thb7PXcVTI2GDBIQZipBgVGoK2ukTawpAA-iTnMlDFYxQOTyKKSlyZ6ynaZt4DnjJte1zPKpxV4VwhWmcolJoda5rDA5TCL2fujV0vY047TbxVXpyw2py1EBEXszit4Ebo0_Cc1INaMA0WH7E2gkZW8k5b-MJGIHQbHjbYabH945_3m2Ck3ljauxeTCDsh_amzL1P-PSalXEXo_NOChppcU00N6SDPHG0cRIxJ4F8xmfkGXoAvHqF__jw16yRymBbDyU6JDtbLtbeIVZ0raasPv5Op-wB7Pjk9PVxA8PPC7j-CerQQ0W |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQS9IGgLDRQwCBCXiGxi53FAqAtdbdnuqtq2ai8oOLZTVZRkyW6F-qf4jcw4jwoE3HrJIZ44lj0ef2N_ngF4qWOuNTeJK7xMujzWOKXiULki0yI3IQ99Q_uQk2k4OuafTsXpCvxs78IQrbK1idZQ61LRHvlb396BpEOC9_PvLmWNotPVNoVGrRZjc_UDXbbFu72POL6vfH-4e_Rh5DZZBVwlAm_pJolS2IZIZ6YvExMYz3DZFyY0MsR2KymUp2Rs8MFzPwq5RERvKNA6CiVCBljvLVjlAboyPVgd7E4PZtekEq9mOXJ0ytBzCptYRogZbPY8Cr4e_7YC2kQBuPp9Jd539W-Ya5e74T242-BUtlMr1n1YMcU6bOwU6KN_u2KvmWWO2i35dbg9aQ7oN-DzASLK8owM6PmClTmreSRsQPx4Vt9FrAyThWYnZbUwbGboN0NcXUlD2HnBDuXF0j0kXj1ZYjZCR7myNPuy2ITjG-nrB9ArysJsAZNRkosg6ivsVc51LDPtSd_kSSQyBKWeA2_aXk1VE96csmxcpNbNEUnaDYADLzrReR3T429CAxqaToDCcNsXZXWWNrM6VQnF2_cRBySIRKNAqjDO4ijr-6E0ytcObNYD21XTVr79x_vxYFYXpXOdY3GrBmljUhbp9QRw4HlXjMaATnhkYcpLkqF4dbQh48DDWn26PwQBml78-tH_K38Gd0ZHk_10f286fgxrPlF4LFFpG3rL6tI8QQy2zJ42is_gy03PtV-WzEG9 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcELQFFgoYBIhL1Gxi53FAqEtZtSytqpaKvVTBsSdVRUmW7Faof41fx4zzqEDArZc9xLPOrj0z_sb-PAPwwibSWompp_xcezKxZFJJZDyVW1VgJKMAeR9ybz_aOZYfpmq6BD-7uzBMq-x8onPUtjK8R74ZuDuQfEiwWbS0iIPt8dvZd48rSPFJa1dOo1GRCV7-oPBt_mZ3m-b6ZRCM3396t-O1FQY8o0J_4aWpMfR7YpvjUKcYoo9SDxVGqCP6D0Yr4xudIH3IIogjqQndIyddJ6FU6ZD6vQE341AN2cbiaXxFL_EbvqOk8IxiqKjNakTowdXR4zTsyW9roSsZQOvgV2aA1_8GvG7hG9-B2y1iFVuNit2FJSxXYW2rpGj926V4JRyH1G3Or8LKXntUvwYnB4Qtq1N2pWdzURWiYZSIETPlRXMrsUahSys-V_UcxSHya8a0zrKuiLNSHOnzhXfEDHv2yWKHQubaEe6rch2Or2Wk78FyWZX4AISO00KF8dDQqEppE51bXwdYpLHKCZ76A3jdjWpm2kTnXG_jPHMBj0qzfgIG8LwXnTXZPf4mNOKp6QU4Ibd7UNWnWWvfmUk5835AiCAlTBqH2kRJnsT5MIg0msAOYL2Z2L6brvONP55PRodNUzazBTV3apC1zmWeXZnCAJ71zeQW-KxHl1hdsAxnruOtmQHcb9Snf0MYkhOmbz_8f-dPYYUsLPu4uz95BLcC5vI4xtIGLC_qC3xMYGyRP3FaL-DLdZvZLyMNRI0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathogenesis+of+Higher+Blood+Pressure+and+Worse+Renal+Function+in+Salt-Sensitive+Hypertension&rft.jtitle=Kidney+%26+blood+pressure+research&rft.au=Yuguang+Chu&rft.au=Yan+Zhou&rft.au=Shihua+Lu&rft.au=Feng+Lu&rft.date=2021-04-01&rft.pub=Karger+Publishers&rft.issn=1420-4096&rft.eissn=1423-0143&rft.volume=46&rft.issue=2&rft.spage=236&rft.epage=244&rft_id=info:doi/10.1159%2F000515088&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c934962130954573ac68b87b126aec2d |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-4096&client=summon |